Mikael joined Redoxis as a Senior Scientist in 2022 after completing his PhD in hematopoietic stem cell biology at Lund University. His research background includes expertise in flow cytometry, cell culture, and cellular immunology.
At Redoxis, Mikael contributes to the development and execution of in vitro studies, supporting assay development, data analysis, and study design across a range of immunological applications.
His work strengthens the in vitro platform at Redoxis and supports the generation of robust preclinical data within inflammation and immune-mediated diseases.
